FDA Approved: VYEPTI — Supplemental Application (Lundbeck Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for VYEPTI (eptinezumab-jjmr) filed by Lundbeck Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• VYEPTI (eptinezumab)

Snippet

SUPPL AP for VYEPTI (EPTINEZUMAB-JJMR)